ATC Group: A03AX Other drugs for functional bowel disorders

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03AX in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A03 Drugs for functional gastrointestinal disorders
3 A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS
4 A03AX Other drugs for functional bowel disorders

Group A03AX contents

Code Title
A03AX01 Fenpiprane
A03AX02 Diisopromine
A03AX03 Chlorbenzoxamine
A03AX04 Pinaverium
A03AX05 Fenoverine
A03AX06 Idanpramine
A03AX07 Proxazole
A03AX08 Alverine
A03AX09 Trepibutone
A03AX10 Isometheptene
A03AX11 Caroverine
A03AX12 Phloroglucinol
A03AX13 Silicones
A03AX14
A03AX15
A03AX30 Trimethyldiphenylpropylamine
A03AX58 Alverine, combinations

Active ingredients in A03AX

Active Ingredient

Alverine is a drug used for functional gastrointestinal disorders. Alverine is a smooth muscle relaxant used to relieve cramps or spasms of the stomach and intestines. It acts directly on the muscle in the gut, causing it to relax. It is used in the treatment of irritable bowel syndrome. It has a role as an antispasmodic drug.

Dimeticone is used in many pharmaceutical and cosmetic preparations. A 4% concentration has been found to affect the physico-physiological activity of lice.

Fenoverine is a calcium antagonist that inhibits the calcium channels at significant sites in the calcium transport system. It stops the rapid calcium influx through the voltage-dependent channels and inhibits the rapid calcium release from the intracellular storage sites. This induces an effect on the strong (transient and prolonged), asynchronous spasmodic contractions. Fenoverine is a potent, musculotropic, spasmolytic agent that affects primarily the gastrointestinal tract, bile duct, and female genital organs.

Simethicone is a chemically inert, non-systemic gastric defoaming agent that works by altering the elasticity of interfaces of mucus-embedded bubbles in the gastrointestinal tract. The gas bubbles are thus broken down or coalesced and in this form gas is more easily eliminated through eructation or passing flatus.

Related product monographs

Document Type Information Source  
 DENTINOX INFANT COLIC DROPS Oral suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 INFACOL Oral suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 METEOSPASMYL Soft capsule MPI, EU: SmPC Marketing Authorisation Holder
 SPASMONAL Hard capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SPASMOPRIV FORTE Capsule MPI, EU: SmPC Web Search